Care este prețul pentru Molecular Pharmacology (USA), Ltd. (MLPH)

Prețul pentru Molecular Pharmacology (USA), Ltd. (MLPH) este $0.0322

Care este capitalizarea de piață pentru Molecular Pharmacology (USA), Ltd. (MLPH)

Capitalizarea de piață pentru Molecular Pharmacology (USA), Ltd. (MLPH) este $643.71K

Molecular Pharmacology (USA), Ltd. (MLPH) Splituri de Acțiuni

As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain. These products are offered in diverse dosage forms, formulations, and packaging options to suit various needs. MLPH's marketing strategy involves leveraging pharmaceutical distributors and forging collaborative partnerships with companies in the United States and Europe. Additionally, the company maintains an agreement with Dermatology Development Corporation to jointly develop and market a suite of therapeutic, cosmetic, and cosmeceutical items derived from the ThermaLIFE product line and its core active component. Headquartered in Perth, Australia, Molecular Pharmacology (USA) Limited operates as a subsidiary of PharmaNet Group Limited.

An	Split	Multiplu	Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.

Split

Multiplu

Multiplu cumulativ

Nu sunt suficiente date pentru perioada selectată.

Companie	Număr total de splituri	Multiplu cumulativ	Țara
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Companie

Număr total de splituri

Multiplu cumulativ

Țara